India, June 20 -- Quantum BioPharma Ltd. (QNTM) is having a banner year in 2025, with its share price skyrocketing 730% year-to-date.
This biopharmaceutical company is focused on addressing critical unmet needs in treating challenging neurodegenerative and metabolic disorders and alcohol misuse disorders.
Formerly operating as FSD Pharma, Quantum BioPharma is the developer of unbuzzd, a scientifically formulated beverage designed to accelerate alcohol metabolism, thereby reducing both intoxication symptoms and hangover effects.
In 2023, Quantum BioPharma entered into a licensing agreement with privately held Celly Nutrition, granting exclusive rights for the recreational use of its alcohol detoxification technology. Under the terms of th...